The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters
Official Title: A Retrospective Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters
Study ID: NCT01586026
Brief Summary: This study is to compare the rate of adverse events in subjects with maintenance flushes greater than 28 days.
Detailed Description: This study is a retrospective, multi-center data collection study to support extending the maximum recommended maintenance flushing intervals in subjects who have Bard totally implanted ports with distally-valved catheters. This study is intended to provide clinical evidence in support of extending the maximum recommended maintenance flushing interval to a time point of potentially \>28 days for Bard ports with distally-valved catheters. Reduction in the number of maintenance flushes could help alleviate the inconvenience, reduce the time and expense, and minimize the invasive nature of the maintenance flushing procedure for patients and medical institutions. Subjects will be eligible for analysis of the primary endpoint after the first successful maintenance flush of the port until (a) the first adverse event or (b) abandonment of the port. A financial analysis will be performed on an institutional basis to determine the approximate mean cost of flushing. These costs will be extrapolated into an approximate per-patient cost for the different flushing period durations. No financial information will be collected from subject medical records. All required information will be extrapolated from site staff.
Minimum Age: 21 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Quincy Medical Group, Quincy, Illinois, United States
Willis Knighton Cancer Center, Shreveport, Louisiana, United States
St. Luke's Hospital, Chesterfield, Missouri, United States
Southeast Nebraska Cancer Center, Lincoln, Nebraska, United States
Alegent Research Center, Omaha, Nebraska, United States
Name: Michael McNamara, MD
Affiliation: Alegent Health
Role: PRINCIPAL_INVESTIGATOR